Study of the Action of Flavonoids on Xanthine-Oxidase by Molecular Topology

Journal of Chemical Information and Computer Sciences

Volumn 40, Issue 4, 2000, Pages 1039-1045

  Ponce, A M ^a   Blanco, S E ^a   Molina, A S ^a   Garcia Domenech R ^b   Galvez J ^b  

^a UNIVERSIDAD NACIONAL DE SAN LUIS   (Argentina)

^b UNIVERSITY OF VALENCIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ENZYME INHIBITOR; FLAVONOID; XANTHINE OXIDASE;

ANIMAL; ARTICLE; CHEMICAL MODEL; CHEMISTRY; DISCRIMINANT ANALYSIS; DRUG ANTAGONISM; IN VITRO STUDY; STRUCTURE ACTIVITY RELATION; ULTRAVIOLET SPECTROPHOTOMETRY;

ANIMALS; DISCRIMINANT ANALYSIS; ENZYME INHIBITORS; FLAVONOIDS; MODELS, CHEMICAL; SPECTROPHOTOMETRY, ULTRAVIOLET; STRUCTURE-ACTIVITY RELATIONSHIP; XANTHINE OXIDASE;

EID: 0034221053     PISSN: 00952338     EISSN: None     Source Type: Journal    
DOI: 10.1021/ci000020k     Document Type: Article

References (55)

1. Mori, A,; Nishino, C.; Enoki, N.; Tawata, S. Antibacterial activity and mode of action of plant flavonoids against Proteus vulgaris and Staphylococcus aureus. Phytochemistry 1987, 26, 2231-2234.
2. Linuma, M.; Tsuchiya, H.; Sato, M.; Yokoyama, J.; Ohyama, M.; Ohkawa, Y.; Tanaka, T.; Fujuwara, S.; Fujii, T. Flavanones with potent antibacterial activity against methicillin-resistant Staphylococcus aureus. J. Pharm. Pharmacol. 1994, 46, 892-895.
3. Ertan, M. Studies on the synthesis of some flavonoids derivatives possesing spasmolytic activity. Arch. Pharm. (Weinheim) 1987, 320, 1132-1138.
4. Valenzuela, A.; Campos, R.; Garrido, A. Estudios sobre el mecanismo bioquímico de acción del flavonoide silybina: Relación con sus propiedades terapéuticas. Arch. Biol. Med. Exp. 1988, 21, 75-83.
5. Rastelli, G.; Costantino, L.; Albasini, A. A model of the interaction of substrates and inhibitors with Xanthine Oxidase. J. Am. Chem. Soc. 1997, 119, 3007-3016.
6. Shukla, M. K.; Mishra, P. C. Electronic spectra and structure of allopurinol: A xanthine oxidase inhibitor. Spectrochim, Acta 1996, 52, 1547-1557.
7. Kopcikova, Y.; Rotrekl, V.; Suchy, V.; Brzobohaty, B. Flavonoids: novel beta-glucosidase inhibitors. Chemicke Listy 1996, 90, 599-599.
8. Bezakova, L.; Kartnig, T.; Psenak, M. Effect of flavonoids of Hypericum perforatum L. on lipoxygenase activity. Chemicke Listy 1996, 90, 697-698.
9. Bohmont, C.; Aaronson, L. M.; Mann, K.; Pardini, R. S. J. Inhibition of mitochondrial NADH oxidase, Succinoxidase, and Atpase by naturally occurring flavonoids. J. Nat. Products 1987, 50, 427-433.
10. Hayashi, T.; Sawa, K.: Kawasaki, M.; Arisawa, M.; Shimizu, M.; Monta, N. Inhibition of cow's milk xanthine oxidase by flavonoids. J. Nat. Products 1988, 51, 345-348.
11. Hille, R.; Sprecher, H. On the mechanism of action of xanthine oxidase. J. Biol. Chem. 1987, 262, 10914-10917.
12. Marx, G.; Chevion, M. Site-especific modification of albumin by free radicals. Reaction with cooper (II) and ascorbate. Biochem. J. 1986, 236, 397-400.
13. Craig, D. B.; Arriaga, E. A.; Wong, J. C. Y.; Lu, H.; Dovichi, N. J. Studies on single alkaline phosphatase molecules: reaction rate and activation energy of a reaction catalyzed by a single molecule and effect of thermal denaturation. The death of an enzyme. J. Am. Chem. Soc. 1996, 118, 5245-5253.
14. Silverman, R. B. Mechanism-Based Enzyme Inactivators. In Contemporary Enzyme Kinetics and Mechanism, 2nd ed.; Purich, D. L., Ed.; Academic Press: New York, 1996; pp 291-334.
15. Stutz, A. E. A novel approach for clarifying the reaction mechanism of retaining glycoside hydrolases. Angew. Chem. Intl. 1996, 35, 1926-1928.
16. McCord, J. M.; Fridovich, I. The reduction of cytochrome c by milk xanthine oxidase. J. Biol. Chem. 1968, 243, 5753-5760.
17. Akaike, T.; Ando, M.; Oda, T.; Doi, T.; Ijiri, S.; Araki, S.; Maeda, H. Dependence on O-2 generation by xanthine oxidase of pathogenesis of influenza virus infection in mice. J. Clin. Invest. 1990, 85, 739-745.
18. Granger, D. N. Role of xanthine oxidase and granulocytes in ischemiareperfusion injury. Am. J. Physiol. 1988, 255, 1269-1275.
19. Hamer, I.; Wattiaux, R.; Coninck, S. W. Deleterious effects of xanthine oxidase on rat liver endothelial cells after ischemia/reperfusion. Biophys. Acta 1995, 1269, 145-153.
20. Costantino, L.; Albasini, A.; Rastelli, G.; Benvenuti, S. Activity of polyphenolic crude extracts as scavengers of superoxide radicals and inhibitors of xanthine oxidase. Planta. Med. 1992, 58, 342-344.
21. Cotelle, N.; Bernier, J. L.; Catteau, J. P.; Pommery, J.; Wallet, J. C.; Gaydou, E. M. Antioxidant properties of hydroxy-flavones. Free Radic. Biol. Med. 1996, 20, 35-43.
22. Costantino, L.; Rastelli, G.; Albasini, A. A rational approach to the design of flavones as xanthine oxidase inhibitors. Eur. J. Med. Chem. 1996, 31, 693-699.
23. Randic, M. In Search of Structural Invariants. J. Math. Chem. 1992, 9, 97-146.
24. Kier, L. B.; Hall, L. H. Molecular connectivity in structure - activity analysis; Research Studies Press: Letchworth, England. 1986.
25. Muñoz, C.; de Julián-Ortiz, J. V.; Gimeno, C.; Catalán, V.; Gálvez, J. Detección y ensayos de nuevos compuestos actives trente a virus Herpes Simplex tipo 1. Rev. Esp. Quimioter. 1994, 7, 279-280.
26. Gálvez, J.; García, R.; de Julián-Ortiz, J. V.; Soler, R. Topological Approach to Drug Design. J. Chem. Inf. Cornpul. Sci. 1995, 35, 272-284.
27. Antón-Fos, G. M.; García-Domenech, R.; Perez-Gimenez, F.; Peris-Ribera, J. E.; García-March, F. J.; Salabert-Salvador, M. T. Pharmacological studies of the two new hypoglycaemic compounds 4-(4-methyl-5-oxo-2-pyrazolin-1-y1) benzoic acid and 1-(mesitylen-2-sulfonyl)1-H-1,2,4-triazole. Arzneim-Forsch/Drug Res. 1994, 44, 821-826.
28. Gálvez, J.; García-Domenech, R.; de Gregorio-Alapont, C.; de Julián-Ortiz, J. V.; Salabert-Salvador, M. T.; Soler, R. Advances in molecular similarity; JAI Press Inc.: 1996; Vol. 1, pp 267-280.
29. García-Domenech, R.; de Gregorio-Alapont, C.; de Julián-Ortiz, J. V.; Galvez, J.; Popa, L. Molecular Connectivity to Design β-Blockers with Low Toxicity. Bioorg. Med. Chem. Lett. 1997, 7, 567-572.
30. Gálvez, J.; García, R.; de Julián-Ortiz, J. V.; Soler, R. Topological Approach to Analgesia. J. Chem. Inf. Comput. Sci. 1994, 34, 1198-1203.
31. García-Domenech, R.; García-March, F. J.; Soler, R.; Gálvez, J.; Antón-Fos, G. M.; de Julián-Ortiz, J. V. New analgesics designed by Molecular Topology. Quant. Struct.-Act. Relat. 1996, 15, 201-207.
32. Rios-Santamarina, I.; Gálvez, J.; García-Domenech, R.; Cortijo, J.; Santamaria, P.; Morcillo, E. New Bronchodilators Selected by Molecular Topology. Bioorg. Med. Chem. Lett. 1998, 8, 477-482.
33. Estrada, E.; Peña, P.; García-Domenech, R. Designing sedative/ hypnotic compounds from a novel substructural graph-theoretical approach. J. Comput. Aid. Mol. Des. 1988, 12, 583-595.
34. Pastor, L.; García-Domenech, R.; Wolski, S.; García, M. D.; Gálvez, J. New antifungals selected by molecular topology. Bioorg. Med. Chem. Lett. 1998, 8, 2577-2582.
35. Gozalbes, R.; Gálvez, J.; Moreno, A.; García-Domenech, R. New Antimalarials Found by Molecular Connectivity. J. Pharm. Pharmacol. 1999, 51, 111-117.
36. Gozalbes, R.; Gálvez, J.; García-Domenech, R.; Derouin, F. Molecular search of new active drugs against Toxoplasma gondii, SAR and QSAR. Environ. Res. 1999, 10, 47-60.
37. Gálvez, J.; Gomez-Lechón, M. J.; García-Domenech, R.; Castell, J. V. New Cytostatic Agents Obtained by Molecular Topology. Bioorg. Med. Chem. Lett. 1996, 6, 2301-2306.
38. Kier, L. B.; Murray, W. J.; Randic', M.; Hall, L. H. Connectivity Series Concept Applied to Density. J. Pharm. Sci. 1976, 65, 1226-1230.
39. Kier, L. B.; Hall, L. H. Molecular connectivity In chemistry and drug research; Academic Press: London, 1976; pp 46-79.
40. Gálvez, J.; García, R.; Salabert, M. T.; Soler, R. Charge Indexes. New Topological Descriptors. J. Chem. Inf. Comput. Sci. 1994, 34, 520-525.
41. Collous, T. Discriminant Analysis and Applications: Academic Press: New York, 1973.
42. Dixon, W. J. Manual BMD 'Biomedical Computer Programs'; University of California Press: Los Angeles, 1982.
43. Pederiva, R.; Kavka, J.; D'Arcángelo, A. T. Chalconas y flavanonas aisladas de Zuccagnia punctata Cav. Anal. Asodación Quím. Argentina 1975, 63, 85-90.
44. Wagner, H.; Farkas, L. Synthesis the Flavonoids. In The Flavonoids, Part I; Harborne, J. B., Mabry, T. J., Mabry, H., Eds.: Academic Press: New York, 1975; p 131.
45. Geissman, T. A.; Clinton, R. O. Flavanones and related compounds. I. The preparation of polyhydroxychalcones and flavanones, J. Am. Chem. Soc. 1946, 68, 697-700.
46. Debattista, N. B.; Blanco, S. E.; Pappano, N. B.; Kavka, J.; Ferretti, F. H. Equilibrio químico y cinética de reacción: diseño de experiencias para su enseñanza simultánea. Rev. Soc. Quim. Mex. 1987, 31, 30-36.
47. Holmer, S. A.; Houlton, C. L.; Westmoreland, T. D. A new irreversibly inhibited form of xanthine oxidase from ethylisonitrile. J. Inorg. Biochem. 1997, 66, 63-65.
48. Morel, I.; Lescoat, G.; Cogrel, P.; Sergent, O.; Pazdecoup, N.; Brissot, P.; Cillard, P.; Cillard, J. Antioxidant and iron-chelating activities of the flavonoids catechin, quercetin and diosmetin on iron-loaded rat hepatocyte cultures. Biochem. Pharmacol. 1993, 1, 13-19.
49. Salah, N.; Miller, N. J.; Paganga, G.; Tijburg, L.; Bolwell, G. P.; Evans, C. R. Polyphenolic flavonols as scavenger of aqueous phase radicals and as chain-breaking antioxidants. Arch. Biochem. Biophvs. 1995, 2, 339-346.
50. Bors, W.; Hellers, W.; Michel, C; Saran, M. Radical chemistry of antioxidant flavonoids. In Antioxidants in therapy and preventive medicine; Emerit, Ed.; Plenum Press: New York, 1990; Vol. 1, pp 165-170.
51. Bors, W.; Hellers, W.; Michel, C.; Saran, M. Flavonoids as antioxidants. Determination of radical-scavenging efficiencies. In Methods in enzymology; Packer, L., Glazer, A. N., Eds.; Academic Press: San Diego, CA, 1990; Vol. 186, pp 343-355.
52. Osada, Y.; Tsuchimoto, M.; Fukushima, H.; Takahashi, K.; Kondo, S.; Hasegawa, M.; Komoriya, K. Hypouricemic effect of the novel xanthine oxidase inhibitor, TEI-6720, in rodents. Eur. J. Pharmacol. 1993 Sep 14; 241(2-3), 183-8.
53. Chang, W. S.; Chang, Y. H.; Lu, F. J.; Chiang, H. C. Inhibitory effects of phenolics on xanthine oxidase. Anticancer Res. 1994 Mar-Apr; 14(2A), 501-6.
54. Foye, W. O. Principles de Química Farmacéutica; De. Reverté, SA: Barcelona, 1988; p 618.
55. The Merck Index, 12th ed.; Budavari, S., Ed.; Merck: Rahway, NJ, 1996.